Kabra Drugs has informed that Kabra Drugs having CIN: L02423MP1989LC005438, has authorized to Skyline Financial Services, Share Transfer Agent, registered with SEBI vide registration number INR000003241 for all activities in relation for both Physical and Electronic Transfer facility for the year ended 31.03.2022, under regulation 7(2) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. The certificate has issued in compliance of regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
